Premium
Drug Therapy for Gender Transitions and Health Screenings in Transgender Older Adults
Author(s) -
Mahan Rebecca J.,
Bailey Trista Askins,
Bibb Teryn J.,
Fenney Megan,
Williams Tara
Publication year - 2016
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/jgs.14350
Subject(s) - medicine , transgender , health care , gerontology , pharmacotherapy , medline , family medicine , population , psychiatry , psychology , environmental health , political science , psychoanalysis , law , economics , economic growth
Abstract Transgender medicine is a relatively new field in health care, with only a small amount of evidence‐based literature available for reference. This is especially true for the older adult population, for whom most information must be extrapolated from younger adults. Be it a newly transitioned older adult or a transgendered individual who has been undergoing hormonal therapy for many years, it is important that healthcare professionals be aware of the significant effects that transgender pharmacotherapy can have on older adults. Healthcare providers must also recommend appropriate preventative screenings to transgendered persons.